![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
SS Lau, BA Hill, RJ Highet and TJ Monks
Division of Pharmacology and Toxicology, College of Pharmacy, University of Texas, Austin 78712.
The chemical reaction of 1,4-benzoquinone with glutathione results in the formation of adducts that exhibit increasing degrees of glutathione substitution. Purification of these adducts and analysis by 1H and 13C nuclear magnetic resonance spectroscopy revealed the products of the reaction to be 2-(glutathion-S-yl)hydroquinone; 2,3-(diglutathion-S- yl)hydroquinone; 2,5-(diglutathion-S-yl)hydroquinone; 2,6(diglutathion- S-yl)hydroquinone; 2,3,5-(triglutathion-S-yl)hydroquinone; and 2,3,5,6- (tetraglutatathion-S-yl)hydroquinone. The initial conjugation of 1,4- benzoquinone with glutathione did not significantly affect the oxidation potential of the compound. However, subsequent oxidation and glutathione addition resulted in the formation of conjugates that, dependent upon the position of addition, become increasingly more difficult to oxidize. Increased glutathione substitutions, which resulted in an increase in oxidation potentials, paradoxically resulted in enhanced nephrotoxicity. The triglutathion-S-yl conjugate was the most potent nephrotoxicant; the diglutathion-S-yl conjugates exhibited similar degrees of nephrotoxicity; the mono- and tetraglutathion-S-yl conjugates were not toxic. Thus, with the exception of the fully substituted isomer, the severity of renal necrosis correlated with the extent of glutathione substitution. The lack of toxicity of the fully substituted isomer is probably a consequence of its inability to alkylate tissue components. Thus, the conjugation of glutathione with quinones does not necessarily result in detoxification, even when the resulting conjugates are more stable to oxidation. The inhibition of gamma-glutamyl transpeptidase by AT-125 protected against 2,3,5- (triglutathion-S-yl)hydroquinone-mediated nephrotoxicity. It is suggested that other extra-renal sites expressing relatively high levels of gamma-glutamyl transpeptidase might therefore also be susceptible to hydroquinone-linked glutathione conjugate toxicity. This pathway might also contribute to the carcinogenicity and mutagenicity of certain quinones.
This article has been cited by other articles:
|
|
 |
|
  R. Snyder Benzene's toxicity: a consolidated short review of human and animal studies by HA Khan Human and Experimental Toxicology, September 1, 2007; 26(9): 687 - 696. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Y. Yang, S. S. Lau, and T. J. Monks 2,3,5-tris(Glutathion-S-yl)hydroquinone (TGHQ)-Mediated Apoptosis of Human Promyelocytic Leukemia Cells Is Preceded by Mitochondrial Cytochrome c Release in the Absence of a Decrease in the Mitochondrial Membrane Potential Toxicol. Sci., July 1, 2005; 86(1): 92 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Jia, M. D. Person, J. Dong, J. Shen, S. C. Hensley, J. L. Stevens, T. J. Monks, and S. S. Lau Grp78 is essential for 11-deoxy-16,16-dimethyl PGE2-mediated cytoprotection in renal epithelial cells Am J Physiol Renal Physiol, December 1, 2004; 287(6): F1113 - F1122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Poet, H. Wu, J. C. English, and R. A. Corley Metabolic Rate Constants for Hydroquinone in F344 Rat and Human Liver Isolated Hepatocytes: Application to a PBPK Model Toxicol. Sci., November 1, 2004; 82(1): 9 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dong, S. Ramachandiran, K. Tikoo, Z. Jia, S. S. Lau, and T. J. Monks EGFR-independent activation of p38 MAPK and EGFR-dependent activation of ERK1/2 are required for ROS-induced renal cell death Am J Physiol Renal Physiol, November 1, 2004; 287(5): F1049 - F1058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dong, J. I. Everitt, S. S. Lau, and T. J. Monks Induction of ERK1/2 and Histone H3 Phosphorylation within the Outer Stripe of the Outer Medulla of the Eker Rat by 2,3,5-Tris-(Glutathion-S-yl)hydroquinone Toxicol. Sci., August 1, 2004; 80(2): 350 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Abdelmohsen, P. A. Gerber, C. von Montfort, H. Sies, and L.-O. Klotz Epidermal Growth Factor Receptor Is a Common Mediator of Quinone-induced Signaling Leading to Phosphorylation of Connexin-43: ROLE OF GLUTATHIONE AND TYROSINE PHOSPHATASES J. Biol. Chem., October 3, 2003; 278(40): 38360 - 38367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Habib, M. N. Phan, S. K. Patel, D. Li, T. J. Monks, and S. S. Lau Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat Carcinogenesis, March 1, 2003; 24(3): 573 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Troester, A. B. Lindstrom, S. Waidyanatha, L. L. Kupper, and S. M. Rappaport Stability of Hemoglobin and Albumin Adducts of Naphthalene Oxide, 1,2-Naphthoquinone, and 1,4-Naphthoquinone Toxicol. Sci., August 1, 2002; 68(2): 314 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-S. Yoon, T. J. Monks, J. I. Everitt, C. L. Walker, and S. S. Lau Cell proliferation is insufficient, but loss of tuberin is necessary, for chemically induced nephrocarcinogenicity Am J Physiol Renal Physiol, August 1, 2002; 283(2): F262 - F270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Rappaport, S. Waidyanatha, Q. Qu, R. Shore, X. Jin, B. Cohen, L.-C. Chen, A. A. Melikian, G. Li, S. Yin, et al. Albumin Adducts of Benzene Oxide and 1,4-Benzoquinone as Measures of Human Benzene Metabolism Cancer Res., March 1, 2002; 62(5): 1330 - 1337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Guo, J. T. Corbett, G. Yue, Y. C. Fann, S. Y. Qian, K. B. Tomer, and R. P. Mason Electron Spin Resonance Investigation of Semiquinone Radicals Formed from the Reaction of Ubiquinone 0 with Human Oxyhemoglobin J. Biol. Chem., February 15, 2002; 277(8): 6104 - 6110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Troester, A. B. Lindstrom, L. L. Kupper, S. Waidyanatha, and S. M. Rappaport Stability of Hemoglobin and Albumin Adducts of Benzene Oxide and 1,4-Benzoquinone after Administration of Benzene to F344 Rats Toxicol. Sci., March 1, 2000; 54(1): 88 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Weber, T. J. Monks, and S. S. Lau DDM-PGE2-mediated cytoprotection in renal epithelial cells by a thromboxane A2 receptor coupled to NF-kappa B Am J Physiol Renal Physiol, February 1, 2000; 278(2): F270 - F278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Jeong, G. N. Wogan, S. S. Lau, and T. J. Monks Quinol-Glutathione Conjugate-induced Mutation Spectra in the supF Gene Replicated in Human AD293 Cells and Bacterial MBL50 Cells Cancer Res., August 1, 1999; 59(15): 3641 - 3645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Deisinger and J. C. English Bioavailability and Metabolism of Hydroquinone after Intratracheal Instillation in Male Rats Drug Metab. Dispos., April 1, 1999; 27(4): 442 - 448. [Abstract] [Full Text]
|
|
|
|
|
|
T. J. Weber, T. J. Monks, and S. S. Lau PGE2-mediated cytoprotection in renal epithelial cells: evidence for a pharmacologically distinct receptor Am J Physiol Renal Physiol, October 1, 1997; 273(4): F507 - F515. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
